CAS: 1137-41-3; (4-Aminophenyl)(Phenyl)Methanone

该化合物其结构特征为:由苯并苯核心组成,配有伴有一个芳香环的氨基组;通常是一种固体或晶状物质,以其光吸收特性而著称,使其在各种应用中有用,包括作为太阳屏幕和化妆品中的紫外线过滤器;该化合物在有机溶剂中可中度溶解,但水溶性有限;其化学配方为C13H11NO, 其化学配方既具有芳香性,又具有探明功能组,有助于其再活性和形成氢联结的潜力.4-Aminobenphenone可以进行各种化学反应,包括电益替代和氧化.安全数据表明,应谨慎处理,因为它可能造成皮肤和眼刺激.

结构式图片

相似化合物

611-98-3 2835-78-1 611-79-0

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

N-phenylphthalimide benzoyl chloride benzophenone 4-nitrobenzophenone ethyl (4-benzoylphenyl)carbamate N-(4-benzoylphenyl)acetamide 1-(4-Aminophenyl)-1-phenylethanol 3-nitro-4,4''-imino-di-benzophenone

合成工艺路线路线简述

    N-苯甲酰替苯胺置于甲烷磺酸,四磷十氧化物,Sodium Hydroxide体系中,用 水 用作溶剂,以46%的收率获得4-氨基二苯甲酮
    参考文献:甲磺酸中五氧化二磷存在下苯胺的 Fries 重排
    标题:甲磺酸中五氧化二磷存在下苯胺的 Fries 重排
    摘要:通过与各种路易斯酸(如 Zncl2,Sncl4,Ticl4,Thcl4 和 Bicl3)的光解或热解(高于 200-350oc).乙酰苯胺在沸石催化剂上的 Fries 重排也有报道,在 280oc 下转化率为 50%.19 最近报道了使用强碱通过阴离子重排进行的苯胺 Fries 型重排.20 甲磺酸是一种布朗斯台德酸用作缩合或重排反应的催化剂和溶剂.21-23 它在酚酸酯的 Fries 重排中用作催化剂是已知的.24-26 添加 P2O5 增加了有机化合物在已广泛使用的甲磺酸中的溶解度27 作为我们探索有机转化方法的努力的一部分,28-45 我们描述了在甲磺酸中 Pocl3 存在下合成酰芳基甲磺酸酯的酚酯 Fries 重排的新方法. 46 在此,我们报告了在 P2O5 混合物存在下苯胺的 Fries 重排甲磺酸 (1:7) 作为选择性合成对氨基芳基酮的有效试剂.苯甲酰苯胺 (1A) 的 Fries
    Doi:10.1080/00304940902956093

    海关参考信息

    专利信息


    专利号:US-12251674-B2
    优先权日:2012-11-14
    标 题:Substrates, systems, and methods for array synthesis and biomolecular analysis
    发明人:RAJASEKARAN JOHN J; JAYARAMAN VASANTH; WANG TIANHAO; BEI KANG; KRISHNAMURTHY HARI KRISHNAN; VEDANTHAM PUNITHA
    权利人:VIBRANT HOLDINGS LLC
    摘要:Disclosed herein are formulations, substrates, and arrays. In certain embodiments, substrates and arrays comprise a porous layer for synthesis and attachment of polymers or biomolecules. Also disclosed herein are methods for manufacturing and using the formulations, substrates, and arrays, including porous arrays. Also disclosed herein are formulations and methods for one-step coupling, e.g., for synthesis of peptides in an N→C orientation. In some embodiments, disclosed herein are formulations and methods for high efficiency coupling of biomolecules to a substrate.

    专利号:US-7514465-B2
    优先权日:2004-11-16
    标题 :Synthesis of N2-(substituted arylmethyl)-3-(substituted phenyl)indazoles as novel anti-angiogenic agents
    发明人:KUO SHENG-CHU; HUANG LI-JIAU; LEE FANG-YU; TENG CHE-MING; SHIH MEI-LING; CHEN HUA-SIN
    权利人:YUNG SHIN PHARM IND CO LTD
    摘要:Novel compounds of 2-(substituted arylmethyl)-3-(substituted phenyl)-2H-indazoles and 1-(substituted arylmethyl)-3-(substituted phenyl)-1H-indazoles are synthesized, and useful as anti-angiogenic agents.

    专利号:US-3872218-A
    优先权日:1972-03-06
    标题 :Synthesis of alkali metal tetracarbonylferrates
    发明人:COLLMAN JAMES P; WINTER STANLEY R
    权利人:UNIV LELAND STANFORD JUNIOR
    摘要:Production of alkali metal tetracarbonylferrate by reaction of alkali metal with an iron carbonyl, preferably iron pentacarbonyl (Fe(CO)5), in a suitable solvent and in the presence of an electron carrier. Alkali metal may be in solid phase or liquid phase.

    专利号:US-6849650-B2
    优先权日:1998-02-27
    标 题:Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:THORSETT EUGENE D; PORTER WARREN J; NISSEN JEFFREY S; LATIMER LEE H; AUDIA JAMES E; DROSTE JAMES
    权利人:ATHENA NEUROSCIENCES INC; LILLY CO ELI
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:US-6399628-B1
    优先权日:1996-11-22
    标 题 :N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting alpha- amyloid peptide release and/or its synthesis by use of such compounds
    发明人:AUDIA JAMES E; FOLMER BEVERLY K; JOHN VARGHESE; LATIMER LEE H; NISSEN JEFFREY S; REEL JON K; THORSETT EUGENE D; WHITESITT CELIA A
    权利人:ATHENA NEUROSCIENCES INC; LILLY CO ELI
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:EP-0951466-B1
    优先权日:1996-12-23
    标题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:WU JING; TUNG JAY S; THORSETT EUGENE D; PLEISS MICHAEL A; NISSEN JEFFREY S; NEITZ JEFFREY; LATIMER LEE H; JOHN VARGHESE; FREEDMAN STEPHEN; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; DROSTE JAMES J; HENRY STEVEN S; MCDANIEL STACEY L; SCOTT WILLIAM L; STUCKY RUSSELL D
    权利人:ELAN PHARM INC; LILLY CO ELI
    摘要:Disclosed are compounds for Formula (I) wherein the substituents are as defined in the claims which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.
    湖北瑞凯兴科技股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.hbrkx.com
    企业联系电话:0712-3188051;13795397680👤
    📞湖北瑞凯兴科技股份有限公司 ⚠️参考联系方式
    联系人:廖凯
    电话:0712-3188051;13795397680
    手机:13795397680
    传真:0712-3188051
    邮箱:liaokai@hbrkx.com
    通信地址: 湖北省应城市长江埠赛孚工业园发展二路
    邮编: 430040
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:湖北省应城市长江埠赛孚工业园发展二路
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    武汉信诺得化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.xndhg.com
    企业联系电话:027-85823669;13971036923(微信同号)👤
    📞武汉信诺得化工有限公司 ⚠️参考联系方式
    联系人:吴经理
    电话:027-85823669;13971036923(微信同号)
    手机:13971036923
    传真:027-63377734
    邮箱:whxndhg@163.com
    通信地址: 武汉市江汉区常青路特一号台银大厦806
    邮编: 430015
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:武汉市江汉区常青路特一号台银大厦806
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Takeda, T.; Tsubouchi, A., Science of Synthesis, (2010) 47, 275.
    摘要:Tomás-Gamasa, M., Science of Synthesis: Cross Coupling and Heck-Type Reactions, (2012) 2, 35.
    摘要:Monguchi, Y.; Sajiki, H., Science of Synthesis: Catalytic Reduction in Organic Synthesis, (2017) 2, 353.
    摘要:Martin, A. R., Science of Synthesis: N-Heterocyclic Carbenes in Catalytic Organic Synthesis, (2016) 1, 174.
    摘要:Monguchi, Y.; Sajiki, H., Science of Synthesis: Catalytic Reduction in Organic Synthesis, (2017) 2, 361.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知